February 28, 2019
Advancements for breast cancer patients are being led by breast cancer combination therapy innovations, and off-the-shelf personalized immunotherapy
February 3, 2019
The multibillion-dollar immunotherapy market is expected to experience further growth on advancements in checkpoint inhibitor biotechnology.
December 19, 2018
With 2018 coming to an end, what's the biotech outlook? Next year will bring new investing opportunities for those in...
October 7, 2018
BriaCell CEO Dr. William Williams discusses his company’s success in developing immunotherapies targeting breast and other cancers.
September 26, 2018
BriaCell Therapeutics Corp. (“BriaCell”, the “Company”) (TSXV:BCT) (OTCQB:BCTXF), an immuno-oncology focused biotechnology company with a proprietary targeted immunotherapy technology, is...
September 21, 2018
BriaCell Therapeutics Corp. (TSXV:BCT) (OTCQB: BCTXF) ("BriaCell"), an immuno-oncology focused biotechnology company with a proprietary targeted immunotherapy technology, announced today...